Target intelligence / Profile preview

T-complex 1 pseudogene 3 (TCP1P3)

Target
TCP1P3
Molecular classification
Other (pseudogene)
01

Overview

T-complex 1 pseudogene 3 (TCP1P3) is a pseudogene related by sequence homology to the T-complex 1 (TCP1 or CCT1) gene, which encodes a subunit of the TRiC/CCT chaperonin complex involved in folding actin, tubulin, and other cytosolic proteins[4][7][9]. As a pseudogene, TCP1P3 does not produce a functional protein and is not considered a therapeutic receptor, enzyme, transporter, or drug target. Pseudogenes arise through duplication or retrotransposition and are generally transcriptionally silent, although in rare cases some may regulate gene expression at the RNA level; there is no evidence that TCP1P3 plays such a regulatory role[4][7]. Key context (distinguishing points, based on your schema): - TCP1/CCT1 is an important molecular chaperone, but TCP1P3 refers only to a nonfunctional, pseudogene variant[4][7]. - TCP1P3 is not recognized as a drug target, nor implicated in mechanisms of action, pathway modulation, or any drug interactions[4][7]. - This entry should not be used as a canonical or structured drug target due to its non-coding, pseudogenic nature. Note: If you intended information on the active gene/protein (e.g., "T-complex protein 1 subunit alpha" or "CCT1"), these are distinct functional molecules and should not be confused with TCP1P3[1][7].

Other names
CCT1-1PTCP1L3t-complex 1-like 3TCP1P3
02

Biological functions

Other (pseudogenes do not encode functional proteins)
03

Disease associations

Other (not implicated directly in disease as a coding gene or functional target)

Beyond the preview

Go deeper on T-complex 1 pseudogene 3 (TCP1P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-complex 1 pseudogene 3 (TCP1P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call